[{"NetIncomeLoss_2_Q2_USD":-234428000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":71421000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1120000.0,"PreferredStockValueOutstanding_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":138000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":84062000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"Depreciation_2_Q2_USD":3200000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":54217000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ContractWithCustomerAssetCreditLossExpense_2_Q2_USD":1230000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-1057000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1435000.0,"Liabilities_0_Q2_USD":236090000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":85727000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":53436000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":288678000.0,"Depreciation_1_Q2_USD":1700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1296203.0,"Assets_0_Q2_USD":817457000.0,"AdjustmentsToAdditionalPaidInCapitalOther_1_Q2_USD":7000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":4221000.0,"CommonStockSharesIssued_0_Q2_shares":54284501.0,"IncomeTaxesPaidNet_2_Q2_USD":47000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":2335000.0,"PurchaseObligation_0_Q2_USD":25500000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7837977.0,"CostOfGoodsAndServicesSold_2_Q2_USD":150000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":42174000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":77829000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":232148000.0,"AssetsCurrent_0_Q2_USD":568312000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_1_Q2_USD":-1057000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":127000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":46.6,"OtherAssetsNoncurrent_0_Q2_USD":8286000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-124525000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-4573000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":3136170.0,"InventoryWriteDown_1_Q2_USD":0.0,"InventoryWriteDown_2_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-12000.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q2_USD":830000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-224000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":306035000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":59.37,"ResearchAndDevelopmentExpense_1_Q2_USD":91079000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":175225000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-2018000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1368000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":10475000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":32000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":802000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-23000.0,"CommonStockValue_0_Q2_USD":54000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-233014000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2748000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":650300000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":311000.0,"RestrictedCash_0_Q2_USD":5200000.0,"CostsAndExpenses_1_Q2_USD":133380000.0,"AccountsReceivableNetCurrent_0_Q2_USD":3403000.0,"CostsAndExpenses_2_Q2_USD":253204000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3239000.0,"ContractWithCustomerAssetAllowanceForCreditLossRecovery_2_Q2_USD":400000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":19675000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":36701000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":6.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":128475000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":313325000.0,"ShareBasedCompensation_2_Q2_USD":36387000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":70471000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":314000.0,"AccountsPayableCurrent_0_Q2_USD":5591000.0,"LiabilitiesCurrent_0_Q2_USD":105086000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-210492000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":6000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-21000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":19675000.0,"NonoperatingIncomeExpense_2_Q2_USD":4266000.0,"InterestIncomeExpenseNet_1_Q2_USD":1586000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":269000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":16922000.0,"RestrictedCashNoncurrent_0_Q2_USD":5168000.0,"CommonStockSharesOutstanding_0_Q2_shares":54284501.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2740000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":174254000.0,"InterestIncomeExpenseNet_2_Q2_USD":4490000.0,"LeaseCost_1_Q2_USD":3598000.0,"NonoperatingIncomeExpense_1_Q2_USD":1563000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":17875000.0,"NetIncomeLoss_1_Q2_USD":-123474000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":36745000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q2_USD":128500000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":116000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":7172000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":293846000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":942000.0,"AdditionalPaidInCapital_0_Q2_USD":1762099000.0,"SubleaseIncome_1_Q2_USD":730000.0,"SubleaseIncome_2_Q2_USD":1451000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.082,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1776000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":4886000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":208510.0,"LeaseCost_2_Q2_USD":7258000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1179666000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6660990.0,"OperatingLeaseCost_1_Q2_USD":4328000.0,"OperatingLeaseCost_2_Q2_USD":8709000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":18.93,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":58.4,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":8017000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":308750000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":817457000.0,"InventoryNet_0_Q2_USD":4359000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":9159000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_2_Q2_USD":77.27,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":147000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":233120000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":14985000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":36387000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":8343000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":14510000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2466000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":36688000.0,"StockholdersEquity_0_Q2_USD":581367000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":8589000.0,"ProfitLoss_2_Q2_USD":-234428000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-2.28,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-4.39,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":497000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":7416000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":53667000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_2_Q2_shares":222413.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":138800000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":19528000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2_Q2_shares":17018.0,"EntityListingParValuePerShare_2_Q2_USD":0.001,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]